July 27, 2018 5:22pm

What do three (3) stocks (CRSP, EDIT and NTLA) have in common, they all “had” dropped -7%+ during Friday’s session…

There were NO safe havens as the Dow, NASADAQ and S&P fall

 

Pre-open indications: 4 hits and 2 miss

The close was negative with an Advance/Decline Line (A/DL) of 5/38 and 2 flat;

 

I say today what others won’t, so you can do what others can’t!

Never leave an investor uninformed!  Want to know WHY, WHAT and HOW, subscribe!

 

Henry’omics:

 

In the past eleven sessions, there were 7 negative closes.

Volume was still LOW with a few exceptions:  HSGX to the upside; EDIT, FIXX, GBT, NTLA, XON, SGMO, MDXG and BLUE to the downside

As “earnings” or LPS (loss-per-share) season is a coming full blown next week!

Walk away to the weekend ahead; clear your head and look close at where the next profitable trade … will be!

 

The advance/decline line scenario of 45 covered companies:   

  • The open was negative with an A/DL of 12/30 and 3 flats;
  • The first hour slipped further negative with and A/DL of 5/38 and 2 flats;
  • The mid-day was negative with an A/DL of 3/39 and 3 flats;
  • The close was negative with an A/DL of 5/38 and 2 flat;

 

Pre-open to close indications: 4 hit and 2 miss

  • CRISPR Therapeutics (CSP) closed down -$2.76 – hit;
  • Editas Medicine (EDIT) closed down -$1.84 – hit;
  • Intellia Therapeutics (NTLA) closed down -$1.15 – hit;
  • Fate Therapeutics (FATE) closed down -$0.26 – miss;
  • MiMedx (MDXG) closed down -0.65 – hit;
  • Solid Biosciences (SLDB) closed down -$0.59 – miss;

 

Of the 45 companies covered on Friday; 38 downside equities finished in a range of -$0.01 (PSTI) to -$6.70 (BLUE) while the 5 upside equities oscillated from +$0.01 (KOOL) to $0.16 (MESO) with 2 flat closes.

 

From the pre-open newsletter titled, “after stuttering and stumbling, demanding upside motion. The sector will also be keeping a close eye on the shares of gene editing companies. The IBB signals some hope, indicating a +0.13% upside in Friday’s pre-market” – it just wasn’t so!

 

Last Wednesday’s review of gene editing pricings: Gene editing stocks are a game of pick-up-stick’s trading targets. It’s still relevant … https://www.regmedinvestors.com/articles/10412  

The running commentary of CRSP, EDIT and NTLA … volumes are spiking as downside percentages (%) slow, volume increases as pricing ranges elongate …

  • CRSP (-$2.76 or -5.555% to $47.01) in a day’s range of $45.58 to $50.37 with 1.23 M shares traded <3 moth average = 1.55 M shares>;
  • EDIT (-$1.84 or -5.83% to $29.70) in a day’s range of $29.01 to $31.50 with 1.48 M shares traded <3 month average = 1.01 M shares>;
  • NTLA (-$1.15 or -4.18% to $26.38) in a day’s range of $25.16 to $27.56 with 1.05 M shares traded <3 month average = 914.1 k shares>

It doesn’t seem there is relief on its way …

 

MY working trend (5 largest) lines:

… The greatest volume to the downside:  MDXG, SGMO, XON, EDIT and VSTM

… Upside volume was weighted to:  KOOL, HSGX, MESO, OSIR and BSTG

… Biggest $ downside:  BLUE (-$6.70), AXGN (-$5.15), CRSO (-$2.76), RARE (-$2.59) and BMRN (-$2.24)

 … Best moves to the $ upside:  MESO (+$0.16), BSTG (+$0.15), HSGX (+$0.03), OSIR (+$0.01) and KOOL (+$0.01)

… Flats:  AST and RENE.L

 

The weekly count - decliners versus gainers – looks at the view from different angles:

……. look at the differences in decliners:

  • Friday’s decliners ranged from -0.79% <PSTI -$0.01 > to -13.54% <MDXG -$0.65 > in 38 equities;
  • Thursday’s decliners ranged from -0.11% <FATE -$0.01 > to -6.87% < HSGX -$0.16 > in 28 equities;
  • Wednesday’s decliners ranged from -0.06% < ONCE -$0.05> to -13.51% <BSTG -$0.52 > in 16 equities;
  • Tuesday’s decliners ranged from -0.22% <KOOL -$0.009 > to -10.44% <FATE -$1.14 > in 40 equities;
  • Monday’s decliners ranged from -0.21% <SAGE -$0.36 > to -6.82% <SLDB -$2.94 > in xx equities;
  • Last Friday’s decliners ranged from -0.03% <NTLA (-$0.01 > to -6.97% < MDXG -$0.28> in 24 equities;

Versus

… Look at the percentage’s (%) and spreads …

  • Friday’s gainers ranged from +0.10% <OSIR <+$0.01 > to +4.35% <BSTG +0.15 > in 5 equities;
  • Thursday’s gainers ranged from +0.10% <BMRN +$0.10 > to +10.85% <MDXG +$0.47> in 14 equities;
  • Wednesday’s gainers ranged from +0.23% <BCLI +$0.01 > to +9.62% <MDXG +$0.38 > in 24 equities;
  • Tuesday’s gainers ranged from +1.71% <IONS +$0.76 > to +4.40% < BCLI +$0.18> in 4 equities;
  • Monday’s gainers ranged from +0.46% <FATE +$0.05 > to +18.8% <CUR +$0.22> in 18 equities;
  • Last Friday’s gainers ranged from +0.10% <OSIR +$0.01 > to +4.12% <BLFS +$0.87 > in 15 equities;

 

Daily analytics and metrics:

  • The Dow declined 76.01 points or -0.30% to close at 25,451.06.
  • The NASDAQ dropped 114.77 points or -1.46% to 7,737.42.
  • The S&P 500 fell -18.62 points -0.66%to 2,818.82.

 

The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market:

  • Friday traded at 13.03, up +7.33%
  • Thursday traded at 12.14, down – 1.22%
  • Wednesday traded at 12.29, down -0.12%
  • Tuesday traded at 12.41, down -1.66%
  • Monday traded at 12.62, down -1.87%
  • Last Friday traded at 12.83, down -0.31%

 

The iShares Russell 2000 (IWM) closed:

  • Friday was down -1.85%;
  • Thursday was up +0.51%;
  • Wednesday was up +0.37%;
  • Tuesday was down -1.06%;
  • Monday was up +0.12%;
  • Last Friday was down -0.42%;

 

The iShares NASDAQ Biotechnology (IBB) closed:

  • Friday was down -2.07%
  • Thursday was down -1.24%
  • Wednesday was up +1.11%
  • Tuesday was down -0.14%
  • Monday was down -0.06 %
  • Last Friday was down -0.08%

 

JULY sessions:

Friday closed NEGATIVE with 38 decliners, 5 advancers and 2 flat;

Thursday closed NEGATIVE with 26 decliners, 14 advancers and 5 flat;

Wednesday closed POSITIVE with 16 decliners, 24 advancers and 5 flat;

Tuesday closed NEGATIVE with 40 decliners, 4 advancers and 1 flat;

Monday (7/23) closed NEGATIVE with 25 decliners, 18 advancers and 2 flats;

Last Friday closed NEGATIVE with 24 decliners, 15 advancers and 5 flats;

Thursday closed POSITIVE with 14 decliners, 28 advancers and 2 flats;

Wednesday closed NEGATIVE with 30 decliners, 13 advancers and 2 flat;

Tuesday closed POSITIVE with 13 decliners, 29 advancers and 3 flat;

Monday (7/16) closed NEGATIVE with 32 decliners, 10 advancers and 3 flat;

Friday closed POSITIVE with 17 decliners, 25 advancers and 3 flat;

Thursday closed POSITIVE with 19 decliners, 24 advancers and 2 flat;

Wednesday closed POSITIVE with 18 decliners, 24 advancers and 3 flat;

Tuesday closed NEGATIVE with 29 decliners, 15 advancers and 1 flat;

Monday (7/9) closed POSITIVE with 18 decliners, 22 advancers and 5 flat;

Friday closed POSITIVE with 8 decliners, 35 advancers and 2 flat;

Thursday closed POSITIVE with 18 decliners, 23 advancers and 4 flat;

Wednesday (7/4) was a holiday;

Tuesday closed POSITIVE with 9 decliners, 33 advancers and 3 flat;

Monday (7/2) closed POSITIVE with 15 decliners, 27 advancers and 3 flat;

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.